AHSG and metabolic dysfunction-associated steatotic liver disease: NAFLD is known to increase risk of diabetes, cardiovascular diseases (CVD) in particular atherosclerosis, and chronic kidney disease with implication of hepatokines including fetuin-A [6, 12, 13].